Vasoactive drug use in children with community acquired septic shock in Australia and New Zealand

Elliot Long, The Royal Children's Hospital, CLIFTON HILL, Victoria, Australia; Stephen Hearps, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Amanda Williams, MCRI/RCH, Parkville, Victoria, Australia; Warwick Butt, The Royal Children's Hospital, melbourne, Victoria, Australia; Meredith L. Borland, University of Western Australia, Nedlands, Western Australia, Australia; Simon J. Erickson, Perth Children's Hospital, CLAREMONT WA 6010, Western Australia, Australia; Shefali Jani, SCHN, Castle Hill, New South Wales, Australia; Marino Festa, Children's Hospital at Westmead, Sydney, New South Wales, Australia; Eunicia Tan, The University of Auckland, Auckland, Auckland, New Zealand; Natalie Phillips, Queensland Children’s Hospital, Windsor, Queensland, Australia; Amit Kochar, Womens And Childrens Hospital, ADELAIDE, South Australia, Australia; Simon Craig, Monash University, Clayton, Victoria, Australia; stuart R. Dalziel, Starship Children's Hospital, Auckland, Auckland, New Zealand; Shane George, Griffith University, Gold Coast, Queensland, Australia; Nathan Kuppermann, Children's National Health System, Washington, DC, United States; Franz E. Babl, The Royal Children's Hospital, Melbourne, Victoria, Australia